Critical Care

official impact factor 4.60

This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Highly Access Review

Gram-negative antibiotic resistance: there is a price to pay

Thomas G Slama

Critical Care 2008, 12(Suppl 4):S4 doi:10.1186/cc6820

No comments have yet been made on this article.

Post a comment